158 related articles for article (PubMed ID: 35202431)
1. Detection of EGFR mutations in non-small cell lung cancer by droplet digital PCR.
Williamson DFK; Marris SRN; Rojas-Rudilla V; Bruce JL; Paweletz CP; Oxnard GR; Sholl LM; Dong F
PLoS One; 2022; 17(2):e0264201. PubMed ID: 35202431
[TBL] [Abstract][Full Text] [Related]
2. EGFR Mutations in Cell-free Plasma DNA from Patients with Advanced Lung Adenocarcinoma: Improved Detection by Droplet Digital PCR.
Buder A; Setinek U; Hochmair MJ; Schwab S; Kirchbacher K; Keck A; Burghuber OC; Pirker R; Filipits M
Target Oncol; 2019 Apr; 14(2):197-203. PubMed ID: 30810887
[TBL] [Abstract][Full Text] [Related]
3. Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer.
Sacher AG; Paweletz C; Dahlberg SE; Alden RS; O'Connell A; Feeney N; Mach SL; Jänne PA; Oxnard GR
JAMA Oncol; 2016 Aug; 2(8):1014-22. PubMed ID: 27055085
[TBL] [Abstract][Full Text] [Related]
4. Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.
Seki Y; Fujiwara Y; Kohno T; Takai E; Sunami K; Goto Y; Horinouchi H; Kanda S; Nokihara H; Watanabe S; Ichikawa H; Yamamoto N; Kuwano K; Ohe Y
Oncologist; 2016 Feb; 21(2):156-64. PubMed ID: 26768482
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of PCR-HRM, RFLP, and direct sequencing as simple and cost-effective methods to detect common EGFR mutations in plasma cell-free DNA of non-small cell lung cancer patients.
Zaini J; Syahruddin E; Yunus M; Andarini SL; Hudoyo A; Masykura N; Yasril R; Ridwanuloh A; Hidajat H; Nurwidya F; Suharsono S; Utomo ARH
Cancer Rep (Hoboken); 2019 Aug; 2(4):e1159. PubMed ID: 32721094
[TBL] [Abstract][Full Text] [Related]
6. Developing Ultrasensitive Library-Aliquot-Based Droplet Digital PCR for Detecting T790M in Plasma-Circulating Tumor DNA of Non-small-Cell-Lung-Cancer Patients.
Yang K; Li J; Zhao J; Ren P; Wang Z; Wei B; Dong B; Sun R; Wang X; Groen HJM; Ma J; Guo Y
Anal Chem; 2018 Oct; 90(19):11203-11209. PubMed ID: 30156405
[TBL] [Abstract][Full Text] [Related]
7. Compared to plasma, bronchial washing fluid shows higher diagnostic yields for detecting EGFR-TKI sensitizing mutations by ddPCR in lung cancer.
Lee SH; Kim EY; Kim T; Chang YS
Respir Res; 2020 Jun; 21(1):142. PubMed ID: 32517757
[TBL] [Abstract][Full Text] [Related]
8. Total DNA input is a crucial determinant of the sensitivity of plasma cell-free DNA EGFR mutation detection using droplet digital PCR.
Zhang Y; Xu Y; Zhong W; Zhao J; Chen M; Zhang L; Li L; Wang M
Oncotarget; 2017 Jan; 8(4):5861-5873. PubMed ID: 28052016
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the Amplification Refractory Mutation System, Super Amplification Refractory Mutation System, and Droplet Digital PCR for T790 M Mutation Detection in Non-small Cell Lung Cancer after Failure of Tyrosine Kinase Inhibitor Treatment.
Zhu L; Zhang S; Xun Y; Jiang Y; Xia B; Chen X; Wang L; Jiang H; Ma S
Pathol Oncol Res; 2018 Oct; 24(4):843-851. PubMed ID: 28868565
[TBL] [Abstract][Full Text] [Related]
10. A novel, rapid point-of-care test for lung cancer patients to detect epidermal growth factor receptor gene mutations by using real-time droplet-PCR and fresh liquid cytology specimens.
Asaka S; Yoshizawa A; Matsuda K; Yamaguchi A; Yamamoto H; Shiina T; Nakata R; Ogawa K; Zhang M; Honda T
Oncol Rep; 2017 Feb; 37(2):1020-1026. PubMed ID: 27922678
[TBL] [Abstract][Full Text] [Related]
11. Optimal method for quantitative detection of plasma EGFR T790M mutation using droplet digital PCR system.
Suzawa K; Yamamoto H; Ohashi K; Hashida S; Tomida S; Kubo T; Maki Y; Soh J; Tsukuda K; Kiura K; Miyoshi S; Toyooka S
Oncol Rep; 2017 May; 37(5):3100-3106. PubMed ID: 28405680
[TBL] [Abstract][Full Text] [Related]
12. Multiplex Ultrasensitive Genotyping of Patients with Non-Small Cell Lung Cancer for Epidermal Growth Factor Receptor (EGFR) Mutations by Means of Picodroplet Digital PCR.
Watanabe M; Kawaguchi T; Isa SI; Ando M; Tamiya A; Kubo A; Saka H; Takeo S; Adachi H; Tagawa T; Kawashima O; Yamashita M; Kataoka K; Ichinose Y; Takeuchi Y; Watanabe K; Matsumura A; Koh Y
EBioMedicine; 2017 Jul; 21():86-93. PubMed ID: 28625519
[TBL] [Abstract][Full Text] [Related]
13. A Comparison of ddPCR and ARMS for detecting EGFR T790M status in ctDNA from advanced NSCLC patients with acquired EGFR-TKI resistance.
Wang W; Song Z; Zhang Y
Cancer Med; 2017 Jan; 6(1):154-162. PubMed ID: 28000387
[TBL] [Abstract][Full Text] [Related]
14. A simple and sensitive method for detecting major mutations within the tyrosine kinase domain of the epidermal growth factor receptor gene in non-small-cell lung carcinoma.
Ohnishi H; Ohtsuka K; Ooide A; Matsushima S; Goya T; Watanabe T
Diagn Mol Pathol; 2006 Jun; 15(2):101-8. PubMed ID: 16778591
[TBL] [Abstract][Full Text] [Related]
15. Establishment and validation of a novel droplet digital PCR assay for ultrasensitive detection and dynamic monitoring of EGFR mutations in peripheral blood samples of non-small-cell lung cancer patients.
Tang C; Zhu L; Zhang L; Tan C; Peng Z; Liu B; Liu W; Hu H; Bai Y; Wang B; Lin L; Liang J; Li X; Guo Y; Liu Y
Clin Chim Acta; 2020 Nov; 510():88-96. PubMed ID: 32645388
[TBL] [Abstract][Full Text] [Related]
16. Ultrasensitive and quantitative detection of EGFR mutations in plasma samples from patients with non-small-cell lung cancer using a dual PNA clamping-mediated LNA-PNA PCR clamp.
Zhang S; Chen Z; Huang C; Ding C; Li C; Chen J; Zhao J; Miao L
Analyst; 2019 Feb; 144(5):1718-1724. PubMed ID: 30663747
[TBL] [Abstract][Full Text] [Related]
17. Quantification of plasma EGFR mutations in patients with lung cancers: Comparison of the performance of ARMS-Plus and droplet digital PCR.
Wang L; Guo Q; Yu W; Qiao L; Zhao M; Zhang C; Hu X; Yang G; Xiong L; Lou J
Lung Cancer; 2017 Dec; 114():31-37. PubMed ID: 29173762
[TBL] [Abstract][Full Text] [Related]
18. [Detection of EGFR gene mutations in 100 non-small cell lung cancer clinical samples by a real-time polymerase chain reaction method using amplification refractory mutation system specific primers and Taqman fluorescence probes].
Zhao J; Zhao J; Zhao X; Chen W; Zhong W; Zhang L; Li L; Wang M
Zhongguo Fei Ai Za Zhi; 2013 Jan; 16(1):25-32. PubMed ID: 23327870
[TBL] [Abstract][Full Text] [Related]
19. Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study.
Sueoka-Aragane N; Katakami N; Satouchi M; Yokota S; Aoe K; Iwanaga K; Otsuka K; Morita S; Kimura S; Negoro S;
Cancer Sci; 2016 Feb; 107(2):162-7. PubMed ID: 26577492
[TBL] [Abstract][Full Text] [Related]
20. Therapy Monitoring of EGFR-Positive Non-Small-Cell Lung Cancer Patients Using ddPCR Multiplex Assays.
de Kock R; van den Borne B; Youssef-El Soud M; Belderbos H; Brunsveld L; Scharnhorst V; Deiman B
J Mol Diagn; 2021 Apr; 23(4):495-505. PubMed ID: 33486072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
